CSF1 and graft versus host disease: In vitro, we show that IL-34 is more efficient at inducing FOXP3+ Tregs than CSF-1 and that these FOXP3+ Tregs can efficiently control GVHD in vivo in a model of immune humanized immunodeficient mice.